만성 C형 간질환에서 Interferon 치료반응에 영향을 미치는 인자
Backgound/Aim '. Although interferon-a(IFNa) is currently the most effective antiviral agent for treating patients with chronic hepatitis C, its efficacy is not always reliable. Factors suggested to infruence outcome of IFN-a therapy for chronic hepatitis C are histological activity, level of v...
Gespeichert in:
Veröffentlicht in: | Clinical and molecular hepatology 1996-01, Vol.2 (2), p.176 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | kor |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!